-
1
-
-
33749230793
-
The role of angiotensin II in hypertension and end-organ damage
-
Pool JL. The role of angiotensin II in hypertension and end-organ damage. Int J Clin Pract Suppl 2000; 111: 4-8.
-
(2000)
Int J Clin Pract Suppl
, vol.111
, pp. 4-8
-
-
Pool, J.L.1
-
2
-
-
0034088314
-
Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension
-
Israili ZH. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens 2000; 14: S73-S86.
-
(2000)
J Hum Hypertens
, vol.14
-
-
Israili, Z.H.1
-
3
-
-
0034685168
-
Angiotensin II receptor antagonists
-
Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet 2000; 355: 637-645.
-
(2000)
Lancet
, vol.355
, pp. 637-645
-
-
Burnier, M.1
Brunner, H.R.2
-
4
-
-
25844476905
-
Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection
-
Ruilope LM, Rosei EA, Bakris GL et al. Angiotensin receptor blockers: therapeutic targets and cardiovascular protection. Blood Press 2005; 14: 196-209.
-
(2005)
Blood Press
, vol.14
, pp. 196-209
-
-
Ruilope, L.M.1
Rosei, E.A.2
Bakris, G.L.3
-
5
-
-
0032995743
-
Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats
-
Steen MS, Foianini KR, Youngblood EB, Kinnick TR, Jacob S, Henriksen EJ. Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats. J Appl Physiol 1999; 86: 2044-2051.
-
(1999)
J Appl Physiol
, vol.86
, pp. 2044-2051
-
-
Steen, M.S.1
Foianini, K.R.2
Youngblood, E.B.3
Kinnick, T.R.4
Jacob, S.5
Henriksen, E.J.6
-
6
-
-
0035724736
-
Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats
-
Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 2001; 38: 884-890.
-
(2001)
Hypertension
, vol.38
, pp. 884-890
-
-
Henriksen, E.J.1
Jacob, S.2
Kinnick, T.R.3
Teachey, M.K.4
Krekler, M.5
-
7
-
-
3242706039
-
Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats
-
Ran J, Hirano T, Adachi M. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am J Physiol Endocrinol Metab 2004; 287: E227-E232.
-
(2004)
Am J Physiol Endocrinol Metab
, vol.287
-
-
Ran, J.1
Hirano, T.2
Adachi, M.3
-
8
-
-
0002550360
-
Paracrine effects of angiotensin-converting enzyme and angiotensin-II-receptor inhibition on transcapillary glucose transport in humans
-
Frossard M, Joukhadar C, Steffen G, Schmid R, Eichler HG, Muller M. Paracrine effects of angiotensin-converting enzyme and angiotensin-II-receptor inhibition on transcapillary glucose transport in humans. Life Sci 2000; 66: PL147-PL154.
-
(2000)
Life Sci
, vol.66
-
-
Frossard, M.1
Joukhadar, C.2
Steffen, G.3
Schmid, R.4
Eichler, H.G.5
Muller, M.6
-
9
-
-
24644510705
-
HOPE/HOPE-TOO Study Investigators. Long-term effects of ramipril on cardiovascular events and on diabetes: Results of the HOPE study extension
-
Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S. HOPE/HOPE-TOO Study Investigators. Long-term effects of ramipril on cardiovascular events and on diabetes: Results of the HOPE study extension. Circulation 2005; 112: 1339-1346.
-
(2005)
Circulation
, vol.112
, pp. 1339-1346
-
-
Bosch, J.1
Lonn, E.2
Pogue, J.3
Arnold, J.M.4
Dagenais, G.R.5
Yusuf, S.6
-
11
-
-
0034740517
-
Pharmacology of AT1-receptor blockers
-
Unger T. Pharmacology of AT1-receptor blockers. Blood Press Suppl 2001; 3: 5-10.
-
(2001)
Blood Press Suppl
, vol.3
, pp. 5-10
-
-
Unger, T.1
-
12
-
-
10444283441
-
Therapeutic effects of angiotensin (AT1) receptor antagonists: Potential contribution of mechanisms other than AT1 receptor blockade
-
Schmidt B, Drexler H, Schieffer B. Therapeutic effects of angiotensin (AT1) receptor antagonists: Potential contribution of mechanisms other than AT1 receptor blockade. Am J Cardiovasc Drugs 2004; 4: 361-368.
-
(2004)
Am J Cardiovasc Drugs
, vol.4
, pp. 361-368
-
-
Schmidt, B.1
Drexler, H.2
Schieffer, B.3
-
13
-
-
20844457604
-
Valsartan in elderly isolated systolic hypertension (VALISH) study: Rationale and design
-
Ogihara T, Saruta T, Matsuoka H et al. Valsartan in elderly isolated systolic hypertension (VALISH) study: Rationale and design. Hypertens Res 2004; 27: 657-661.
-
(2004)
Hypertens Res
, vol.27
, pp. 657-661
-
-
Ogihara, T.1
Saruta, T.2
Matsuoka, H.3
-
14
-
-
13944258929
-
Valsartan in chronic heart failure
-
Ripley TL. Valsartan in chronic heart failure. Ann Pharmacother 2005; 39: 460-469.
-
(2005)
Ann Pharmacother
, vol.39
, pp. 460-469
-
-
Ripley, T.L.1
-
15
-
-
0037880398
-
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats
-
Chan P, Wong KL, Liu IM, Tzeng TF, Yang TL, Cheng JT. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats. J Hypertens 2003; 21: 761-769.
-
(2003)
J Hypertens
, vol.21
, pp. 761-769
-
-
Chan, P.1
Wong, K.L.2
Liu, I.M.3
Tzeng, T.F.4
Yang, T.L.5
Cheng, J.T.6
-
17
-
-
0028971924
-
Plasma levels of beta-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine
-
Zheng X, Zhang T, Ding H, Wang C. Plasma levels of beta-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine. Int J Cardiol 1995; 51: 233-244.
-
(1995)
Int J Cardiol
, vol.51
, pp. 233-244
-
-
Zheng, X.1
Zhang, T.2
Ding, H.3
Wang, C.4
-
18
-
-
0025140981
-
Effects of an angiotensin converting enzyme (ACE) inhibitor on plasma endorphin level
-
Kaada B, Woie L. Effects of an angiotensin converting enzyme (ACE) inhibitor on plasma endorphin level. Gen Pharmacol 1990; 21: 693-695.
-
(1990)
Gen Pharmacol
, vol.21
, pp. 693-695
-
-
Kaada, B.1
Woie, L.2
-
19
-
-
0035650637
-
Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats
-
Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 2001; 50: 2815-2821.
-
(2001)
Diabetes
, vol.50
, pp. 2815-2821
-
-
Cheng, J.T.1
Liu, I.M.2
Chi, T.C.3
Tzeng, T.F.4
Lu, F.H.5
Chang, C.J.6
-
20
-
-
0036810873
-
Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats
-
Cheng JT, Liu IM, Tzeng TF, Tsai CC, Lai TY. Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats. Horm Metab Res 2002; 34: 570-576.
-
(2002)
Horm Metab Res
, vol.34
, pp. 570-576
-
-
Cheng, J.T.1
Liu, I.M.2
Tzeng, T.F.3
Tsai, C.C.4
Lai, T.Y.5
-
21
-
-
0032031040
-
Opioid μ receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
-
Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN. Opioid μ receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 1998; 54: 321-326.
-
(1998)
Brain Res Mol Brain Res
, vol.54
, pp. 321-326
-
-
Loh, H.H.1
Liu, H.C.2
Cavalli, A.3
Yang, W.4
Chen, Y.F.5
Wei, L.N.6
-
22
-
-
0035854604
-
Loss of plasma glucose lowering response to cold stress in opioid mu-receptor knock-out diabetic mice
-
Liu IM, Chi TC, Shiao GC, Lin MT, Cheng JT. Loss of plasma glucose lowering response to cold stress in opioid mu-receptor knock-out diabetic mice. Neurosci Lett 2001; 307: 81-84.
-
(2001)
Neurosci Lett
, vol.307
, pp. 81-84
-
-
Liu, I.M.1
Chi, T.C.2
Shiao, G.C.3
Lin, M.T.4
Cheng, J.T.5
-
23
-
-
0035829017
-
Stimulatory effect of phenylephrine on the secretion of β-endorphin from rat adrenal medulla in vitro
-
Cheng JT, Liu IM, Kuo DH, Lin MT. Stimulatory effect of phenylephrine on the secretion of β-endorphin from rat adrenal medulla in vitro. Auton Neurosci Basic Clin 2001; 93: 31-35.
-
(2001)
Auton Neurosci Basic Clin
, vol.93
, pp. 31-35
-
-
Cheng, J.T.1
Liu, I.M.2
Kuo, D.H.3
Lin, M.T.4
-
24
-
-
0344736999
-
Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats
-
Liu IM, Chen WC, Cheng JT. Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 2003; 307: 1196-1204.
-
(2003)
J Pharmacol Exp Ther
, vol.307
, pp. 1196-1204
-
-
Liu, I.M.1
Chen, W.C.2
Cheng, J.T.3
-
25
-
-
0023576328
-
Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effect of insulin treatment
-
Wohaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effect of insulin treatment. Diabetes 1987; 36: 1014-1018.
-
(1987)
Diabetes
, vol.36
, pp. 1014-1018
-
-
Wohaieb, S.A.1
Godin, D.V.2
-
26
-
-
20144373685
-
Review of exercise in prevention of diabetes
-
Ishida T. Review of exercise in prevention of diabetes. Nippon Rinsho 2005; 63 (S2): 513-516.
-
(2005)
Nippon Rinsho
, vol.63
, Issue.S2
, pp. 513-516
-
-
Ishida, T.1
-
27
-
-
0017737881
-
β-endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland
-
Vargo T, Rossier J, Minick S et al. β-endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland. Science 1977; 197: 1367-1369.
-
(1977)
Science
, vol.197
, pp. 1367-1369
-
-
Vargo, T.1
Rossier, J.2
Minick, S.3
-
28
-
-
0022701732
-
Detection of the pro-opiomelanocortin peptide fragments-beta-endorphin and ACTH-in the adrenals of rats and mice by immunohistochemistry
-
Arefolov VA, Dmitriev AD, Tennov AV, Val'dman AV. Detection of the pro-opiomelanocortin peptide fragments-beta-endorphin and ACTH-in the adrenals of rats and mice by immunohistochemistry. Biull Eksp Biol Med 1986; 101: 445-447.
-
(1986)
Biull Eksp Biol Med
, vol.101
, pp. 445-447
-
-
Arefolov, V.A.1
Dmitriev, A.D.2
Tennov, A.V.3
Val'dman, A.V.4
-
29
-
-
0022340458
-
In vivo and in vitro effects of angiotensin II on the release of beta-endorphin-like immunoreactivity
-
Matsumura M, Inoue S, Yamanoi A, Chikamori K, Saito S. In vivo and in vitro effects of angiotensin II on the release of beta-endorphin-like immunoreactivity. Endocrinol Jpn 1985; 32: 233-240.
-
(1985)
Endocrinol Jpn
, vol.32
, pp. 233-240
-
-
Matsumura, M.1
Inoue, S.2
Yamanoi, A.3
Chikamori, K.4
Saito, S.5
-
30
-
-
0020332878
-
[Met5]-enkephalin-like peptides of the adrenal medulla: Release by nerve stimulation and functional implications
-
Hanbauer I, Kelly GD, Saiani L, Yang HY. [Met5]-enkephalin-like peptides of the adrenal medulla: Release by nerve stimulation and functional implications. Peptides 1982; 3: 469-473.
-
(1982)
Peptides
, vol.3
, pp. 469-473
-
-
Hanbauer, I.1
Kelly, G.D.2
Saiani, L.3
Yang, H.Y.4
-
31
-
-
0024495845
-
Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y
-
Hexum TD, Russett LR. Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y. Neuropeptides 1989; 13: 35-41.
-
(1989)
Neuropeptides
, vol.13
, pp. 35-41
-
-
Hexum, T.D.1
Russett, L.R.2
-
32
-
-
0026446055
-
Protein kinase C activators stimulate beta-endorphin secretion from hypothalamic cells
-
Kapcala LP, Weng CF, Juang HH. Protein kinase C activators stimulate beta-endorphin secretion from hypothalamic cells. Brain Res Bull 1992; 29: 553-557.
-
(1992)
Brain Res Bull
, vol.29
, pp. 553-557
-
-
Kapcala, L.P.1
Weng, C.F.2
Juang, H.H.3
-
33
-
-
16344367289
-
Advances in opioid pharmacology
-
Gourlay GK. Advances in opioid pharmacology. Support Care Cancer 2005; 13: 153-159.
-
(2005)
Support Care Cancer
, vol.13
, pp. 153-159
-
-
Gourlay, G.K.1
-
34
-
-
0024215058
-
Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats
-
Ziel FH, Venkatesan N, Davidson MB. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes 1988; 37: 885-890.
-
(1988)
Diabetes
, vol.37
, pp. 885-890
-
-
Ziel, F.H.1
Venkatesan, N.2
Davidson, M.B.3
-
35
-
-
0026607990
-
Mammalian facilitative glucose transporter family: Structure and molecular regulation
-
Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol 1992; 54: 911-930.
-
(1992)
Annu Rev Physiol
, vol.54
, pp. 911-930
-
-
Pessin, J.E.1
Bell, G.I.2
-
36
-
-
20144384097
-
Disorder of glucose metabolism in skeletal muscle
-
Horike N, Asano T. Disorder of glucose metabolism in skeletal muscle. Nippon Rinsho 2005; 63 (S2): 136-140.
-
(2005)
Nippon Rinsho
, vol.63
, Issue.S2
, pp. 136-140
-
-
Horike, N.1
Asano, T.2
-
38
-
-
0037763823
-
Phosphoenolpyruvate carboxylase: Three-dimensional structure and molecular mechanisms
-
Kai Y, Matsumura H, Izui K. Phosphoenolpyruvate carboxylase: three-dimensional structure and molecular mechanisms. Arch Biochem Biophys 2003; 414: 170-179.
-
(2003)
Arch Biochem Biophys
, vol.414
, pp. 170-179
-
-
Kai, Y.1
Matsumura, H.2
Izui, K.3
-
39
-
-
9244220626
-
Gluconeogenesis and glycogenolysis in health and diabetes
-
Boden G. Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 2004; 52: 375-378.
-
(2004)
J Investig Med
, vol.52
, pp. 375-378
-
-
Boden, G.1
-
40
-
-
0017108414
-
Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II
-
Hems DA, Rodrigues LM, Whitton PD. Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II. Biochem J 1976; 160: 367-374.
-
(1976)
Biochem J
, vol.160
, pp. 367-374
-
-
Hems, D.A.1
Rodrigues, L.M.2
Whitton, P.D.3
|